Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  >  CATEGORY RETURNS
CATEGORY RETURNS      
AMC : Category : Scheme :
Axis NIFTY Healthcare ETF
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSun Pharmaceutical Industries Limited19.4473224463.9442
Domestic EquitiesDr. Reddy's Laboratories Limited7.9923129171.6210
Domestic EquitiesApollo Hospitals Enterprise Limited7.974521801.6173
Domestic EquitiesDivi's Laboratories Limited7.890626911.6003
Domestic EquitiesMax Healthcare Institute Limited7.4805157661.5172
Domestic EquitiesCipla Limited7.1907119131.4584
Domestic EquitiesLupin Limited5.857351341.1880
Domestic EquitiesTorrent Pharmaceuticals Limited4.609022150.9348
Domestic EquitiesFortis Healthcare Limited4.3251110340.8772
Domestic EquitiesLaurus Labs Limited4.027382280.8168
Domestic EquitiesAurobindo Pharma Limited3.808759220.7725
Domestic EquitiesGlenmark Pharmaceuticals Limited3.351831890.6798
Domestic EquitiesAlkem Laboratories Limited3.237212390.6565
Domestic EquitiesBiocon Limited2.6825150750.5441
Domestic EquitiesMankind Pharma Limited2.368623950.4804
Domestic EquitiesIPCA Laboratories Limited2.323529430.4712
Domestic EquitiesZydus Lifesciences Limited2.276252990.4616
Domestic EquitiesAbbott India Limited1.41831110.2877
Domestic EquitiesPiramal Pharma Limited0.8844131370.1794
Domestic EquitiesSyngene International Limited0.775540340.1573
Total 99.9215 20.2656
Cash & Cash Equivalents and Net AssetsClearing Corporation of India Ltd0.2756 0.0559
Cash & Cash Equivalents and Net AssetsNet Receivables / (Payables)-0.1971 -0.0400
Total 0.0785 0.0159
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.